<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">NORTRIPTYLINE HYDROCHLORIDE</span><br/>(nor-trip'ti-leen)<br/><span class="topboxtradename">Aventyl, </span><span class="topboxtradename">Pamelor<br/></span><b>Classifications:</b> <span class="classification">central nervous system agent</span>; <span class="classification">psychotherapeutic</span>; <span class="classification">tricyclic antidepressant</span><br/><b>Prototype: </b>Imipramine<br/><b>Pregnancy Category: </b>D<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>10 mg, 25 mg, 50 mg, 75 mg capsules; 10 mg/5 mL solution</p>
<h1><a name="action">Actions</a></h1>
<p>Secondary amine derivative of amitriptyline. Action mechanism unclear. Tricyclic antidepressant (TCA) with fewer sedative
         and anticholinergic effects than imipramine.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Mood elevation may be due to its inhibition of reuptake of norepinephrine at the presynaptic membrane.</p>
<h1><a name="uses">Uses</a></h1>
<p>Endogenous depression. Similar in actions, uses, limitations, and interactions to imipramine.</p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p>Nocturnal enuresis in children.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Acute recovery period after MI; during or within 14 d of MAO inhibitor therapy. Children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Narrow-angle glaucoma, hyperthyroidism, concurrent administration of thyroid medications, concurrent use with electroshock
         therapy.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Antidepressant</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 25 mg t.i.d. or q.i.d., gradually increased to 100150 mg/d<br/><span class="rdage">Geriatric:</span> <span class="rdroute">PO</span> Start with 1025 mg h.s., increase by 25 mg q3d to 75 mg h.s. (max: 150 mg/d)<br/><span class="rdage">Adolescent:</span> <span class="rdroute">PO</span> 3050 mg/d in divided doses<br/><span class="rdage">Child 612 y:</span> <span class="rdroute">PO</span> 1020 mg/d in 34 divided doses<br/><br/><span class="indicationtitle">Nocturnal Enuresis</span><br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> <i>67 y,</i> 10 mg/d; <i>811 y,</i> 1020 mg/d; &gt;<i>11 y,</i> 2535 mg/d given 30 min before h.s.<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give with food to decrease gastric distress.</li>
<li>In older adults, total daily dose may be given once a day h.s. (preferred).</li>
<li>Be aware that Aventyl is a 4% alcohol solution.</li>
<li>Supervise drug ingestion to be sure patient swallows medication.</li>
<li>Store at 15°30° C (59°86° F) in tightly closed container.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> Tremors, hyperhydrosis. <span class="typehead">CV:</span> <span class="speceff-common">Orthostatic hypotension.</span> <span class="typehead">GI:</span> Paralytic ileus, <span class="speceff-common">dry mouth.</span> <span class="typehead">Hematologic:</span> <span class="speceff-life">Agranulocytosis</span> (rare). <span class="typehead">CNS:</span> Drowsiness, confusional state (especially in older adults and with high dosage). <span class="typehead">Skin:</span> Photosensitivity reaction. <span class="typehead">Special Senses:</span> Blurred vision. <span class="typehead">Urogenital:</span> <span class="speceff-common">Urinary retention.</span>
<h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> May decrease some antihypertensive response to <span class="classification">antihypertensives</span>; <span class="classification">cns depressants</span>, <b>alcohol,</b> <span class="classification">hypnotics</span>, <span class="classification">barbiturates</span>, <span class="classification">sedatives</span> potentiate CNS depression; may increase hypoprothrombinemic effect of <span class="classification">oral anticoagulants</span>; <b>ethchlorvynol</b> may cause transient delirium; <b>levodopa,</b> <span class="classification">sympathomimetics</span> (e.g., <b>epinephrine,</b> <b>norepinephrine</b>) pose possibility of sympathetic hyperactivity with hypertension and hyperpyrexia; <span class="classification">mao inhibitors</span> pose possibility of severe reactions: toxic psychosis, cardiovascular instability; <b>methylphenidate</b> increases plasma TCA levels; <span class="classification">thyroid drugs</span> may increase possibility of arrhythmias; <b>cimetidine</b> may increase plasma TCA levels. <span class="typehead"> Herbal:</span> <b>Ginkgo</b> may decrease seizure threshold. <b>St. John's wort</b> may cause <b>serotonin</b> syndrome (headache, dizziness, sweating, agitation). 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Rapidly absorbed from GI tract. <span class="typehead">Peak:</span> 78.5 h. <span class="typehead">Duration:</span> Crosses placenta; distributed in breast milk. <span class="typehead">Metabolism:</span> Metabolized in liver. <span class="typehead">Elimination:</span> Primarily excreted in urine. <span class="typehead">Half-Life:</span> 1690 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Be aware that nortriptyline has a narrow therapeutic plasma level range, or "therapeutic window." Drug levels above
            or below the therapeutic window are associated with decreased rate of response.
         </li>
<li>Therapeutic response may not occur for 2 wk or more.</li>
<li>Monitor BP and pulse rate during adjustment period of TCA therapy. If systolic BP falls more than 20 mm Hg or if there is
            a sudden increase in pulse rate, withhold medication and notify the physician.
         </li>
<li>Notify physician if psychotic signs increase. Because of the small therapeutic window, a substitute TCA may be prescribed
            rather than an increase in dosage.
         </li>
<li>Inspect oral membranes daily if patient is on high doses of TCA. Urge outpatient to report stomatitis or dry mouth. Sore mouth
            can be a major cause of poor nutrition and noncompliance. Consult physician about use of a saliva substitute (e.g., VA-Oralube,
            Moi-Stir).
         </li>
<li>Monitor bowel elimination pattern and I&amp;O ratio. Urinary retention and severe constipation are potential problems, especially
            in older adults. Advise increased fluid intake; consult physician about stool softener.
         </li>
<li>Observe patient with history of glaucoma. Symptoms that may signal acute attack (severe headache, eye pain, dilated pupils,
            halos of light, nausea, vomiting) should be reported promptly.
         </li>
<li>Report reduction or alleviation of fine tremors.</li>
<li>Be aware that alcohol potentiation may increase the danger of overdosage or suicide attempt.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Be aware that your ability to perform tasks requiring alertness and skill may be impaired.</li>
<li>Do not use OTC drugs unless physician approves.</li>
<li>Consult physician about safe amount of alcohol, if any, that can be ingested. Alcohol and nortriptyline both have increased
            effects when used together and for up to 2 wk after the TCA is discontinued.
         </li>
<li>Nortriptyline enhances the effects of barbiturates and other CNS depressants are enhanced.</li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>